|
1
|
Towner RA, Smith N, Saunders D, Brown CA,
Cai X, Ziegler J, Mallory S, Dozmorov MG, Coutinho De Souza P, et
al: OKN-007 Increases temozolomide (TMZ) sensitivity and suppresses
TMZ-resistant glioblastoma (GBM) tumor growth. Transl Onco.
12:320–335. 2019. View Article : Google Scholar
|
|
2
|
Ostrom QT, Gittleman H, Liao P,
Vecchione-Koval T, Wolinsky Y, Kruchko C and Barnholtz-Sloan JS:
CBTRUS statistical report: Primary brain and other central nervous
system tumors diagnosed in the United States in 2010–2014. Neuro
Oncol. 19 (Suppl 5):v1–v88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lai SW, Huang BR, Liu YS, Lin HY, Chen CC,
Tsai CF, Lu DY and Lin C: Differential characterization of
temozolomide-resistant human glioma cells. Int J Mol Sci. 19(pii):
E1272018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kunjachan S, Rychlik B, Storm G, Kiessling
F and Lammers T: Multidrug resistance: Physiological principles and
nanomedical solutions. Adv Drug Deliv Rev. 65:1852–1865. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen C, Hanson E, Watson JW and Lee JS:
P-glycoprotein limits the brain penetration of nonsedating but not
sedating H1-antagonists. Drug Metab Dispos. 31:312–318. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gottesman MM: Mechanisms of cancer drug
resistance. Annu Rev Med. 53:615–627. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Minchinton AI and Tannock IF: Drug
penetration in solid tumours. Nat Rev Cancer. 6:583–592. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rebucci M and Michiels C: Molecular
aspects of cancer cell resistance to chemotherapy. Biochem
Pharmacol. 85:1219–1226. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kiselyov K, van Rossum DB and Patterson
RL: TRPC channels in pheromone sensing. Vitam Horm. 83:197–213.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lehen'kyi V and Prevarskaya N: Oncogenic
TRP channels. Adv Exp Med Biol. 704:929–945. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zholos AV: TRPC5. Handb Exp Pharmacol.
222:129–156. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hong C, Seo H, Kwak M, Jeon J, Jang J,
Jeong EM, Myeong J, Hwang YJ, Ha K, Kang MJ, et al: Increased TRPC5
glutathionylation contributes to striatal neuron loss in
Huntington's disease. Brain. 138:3030–3047. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu Y, Xu Y, Thilo F, Friis UG, Jensen BL,
Scholze A, Zheng J and Tepel M: Erythropoietin increases expression
and function of transient receptor potential canonical 5 channels.
Hypertension. 58:317–324. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Everett KV, Chioza BA, Georgoula C, Reece
A, Gardiner RM and Chung EM: Infantile hypertrophic pyloric
stenosis: Evaluation of three positional candidate genes, TRPC1,
TRPC5 and TRPC6, by association analysis and re-sequen.
Hum Genet. 126:819–831. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma X, Cai Y, He D, Zou C, Zhang P, Lo CY,
Xu Z, Chan FL, Yu S, Chen Y, et al: Transient receptor potential
channel TRPC5 is essential for P-glycoprotein induction in
drug-resistant cancer cells. Proc Natl Acad Sci USA.
109:16282–16287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang P, Liu X, Li H, Chen Z, Yao X, Jin J
and Ma X: TRPC5-induced autophagy promotes drug resistance in
breast carcinoma via CaMKKβ/AMPKα/mTOR pathway. Sci Rep.
7:31582017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mizushima N and Komatsu M: Autophagy:
Renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lamark T, Svenning S and Johansen T:
Regulation of selective autophagy: The p62/SQSTM1 paradigm. Essays
Biochem. 61:609–624. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang Z and Klionsky DJ: Eaten alive: A
history of macroautophagy. Nat Cell Biol. 12:814–822. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kroemer G, Mariño G and Levine B:
Autophagy and the integrated stress response. Mol Cell. 40:280–293.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yorimitsu T and Klionsky DJ: Autophagy:
Molecular machinery for self-eating. Cell Death Differ. 12 (Suppl
2):S1542–S1552. 2005. View Article : Google Scholar
|
|
22
|
Mizushima N, Levine B, Cuervo AM and
Klionsky DJ: Autophagy fights disease through cellular
self-digestion. Nature. 451:1069–1075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jin S and White E: Role of autophagy in
cancer: Management of metabolic stress. Autophagy. 3:28–31. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Levine B: Unraveling the role of autophagy
in cancer. Autophagy. 2:65–66. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Gozuacik D and Kimchi A: Autophagy as a
cell death and tumor suppressor mechanism. Oncogene. 23:2891–2906.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jin S and White E: Tumor suppression by
autophagy through the management of metabolic stress. Autophagy.
4:563–566. 2008. View Article : Google Scholar :
|
|
28
|
Xie CM, Liu XY, Sham KW, Lai JM and Cheng
CH: Silencing of EEF2K (eukaryotic elongation factor-2 kinase)
reveals AMPK-ULK1-dependent autophagy in colon cancer cells.
Autophagy. 10:1495–1508. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eisenberg-Lerner A, Bialik S, Simon HU and
Kimchi A: Life and death partners: Apoptosis, autophagy and the
cross-talk between them. Cell Death Differ. 16:966–975. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cao L, Walker MP, Vaidya NK, Fu M, Kumar S
and Kumar A: Cocaine-mediated autophagy in astrocytes involves
sigma 1 receptor, PI3K, mTOR, Atg5/7, Beclin-1 and induces type II
programed cell death. Mol Neurobiol. 53:4417–4430. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gozuacik D and Kimchi A: Autophagy and
cell death. Curr Top Dev Biol. 78:217–245. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li W, Zhou Y, Yang J, Li H, Zhang H and
Zheng P: Curcumin induces apoptotic cell death and protective
autophagy in human gastric cancer cells. Oncol Rep. 37:3459–3466.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Guo Y and Pei X: Tetrandrine-induced
autophagy in MDA- MB-231 triple-negative breast cancer cell through
the inhibition of PI3K/AKT/mTOR signaling. Evid Based Complement
Alternat Med. 2019:75174312019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sun WL, Chen J, Wang YP and Zheng H:
Autophagy protects breast cancer cells from epirubicin-induced
apoptosis and facilitates epirubicin-resistance development.
Autophagy. 7:1035–1044. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chittaranjan S, Bortnik S, Dragowska WH,
Xu J, Abeysundara N, Leung A, Go NE, DeVorkin L, Weppler SA, Gelmon
K, et al: Autophagy inhibition augments the anticancer effects of
epirubicin treatment in anthracycline-sensitive and -resistant
triple-negative breast cancer. Clin Cancer Res. 20:3159–3173. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Klionsky DJ, Abdelmohsen K, Abe A, Abedin
MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD,
Adeli K, et al: Guidelines for the use and interpretation of assays
for monitoring autophagy (3rd edition). Autophagy. 12:1–222. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim J, Kundu M, Viollet B and Guan KL:
AMPK and mTOR regulate autophagy through direct phosphorylation of
Ulk1. Nat Cell Biol. 13:132–141. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Takeuchi M and Yamamoto T: Apoptosis
induced by NAD depletion is inhibited by KN-93 in a
CaMKII-independent manner. Exp Cell Res. 335:62–67. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Dasgupta B and Seibel W: Compound
C/dorsomorphin: Its use and misuse as an AMPK inhibitor. Methods
Mol Biol. 1732:195–202. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen X, Zhang M, Gan H, Lee JH, Fang D,
Kitange GJ, He L, Hu Z, Parney IF, Meyer FB, et al: A novel
enhancer regulates MGMT expression and promotes temozolomide
resistance in glioblastoma. Nat Commun. 9:29492018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Goldar S, Khaniani MS, Derakhshan SM and
Baradaran B: Molecular mechanisms of apoptosis and roles in cancer
development and treatment. Asian Pac J Cancer Prev. 16:2129–2144.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Si W, Shen J, Zheng H and Fan W: The role
and mechanisms of action of microRNAs in cancer drug resistance.
Clin Epigenetics. 11:252019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shintani T and Klionsky DJ: Autophagy in
health and disease: A double-edged sword. Science. 306:990–995.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xie Z and Klionsky DJ: Autophagosome
formation: Core machinery and adaptations. Nat Cell Biol.
9:1102–1109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Düzen IV, Yavuz F, Vuruskan E, Saracoglu
E, Poyraz F, Göksülük H, Candemir B and Demiryürek S: Leukocyte TRP
channel gene expressions in patients with non-valvular atrial
fibrillation. Sci Rep. 7:92722017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Jennings JJ Jr, Zhu JH, Rbaibi Y, Luo X,
Chu CT and Kiselyov K: Mitochondrial aberrations in mucolipidosis
Type IV. J Biol Chem. 281:39041–39050. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Curcio-Morelli C, Charles FA, Micsenyi MC,
Cao Y, Venugopal B, Browning MF, Dobrenis K, Cotman SL, Walkley SU
and Slaugenhaupt SA: Macroautophagy is defective in
mucolipin-1-deficient mouse neurons. Neurobiol Dis. 40:370–377.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Vergarajauregui S, Connelly PS, Daniels MP
and Puertollano R: Autophagic dysfunction in mucolipidosis type IV
patients. Hum Mol Genet. 17:2723–2737. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Soyombo AA, Tjon-Kon-Sang S, Rbaibi Y,
Bashllari E, Bisceglia J, Muallem S and Kiselyov K: TRP-ML1
regulates lysosomal pH and acidic lysosomal lipid hydrolytic
activity. J Biol Chem. 281:7294–7301. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Farfariello V, Amantini C and Santoni G:
Transient receptor potential vanilloid 1 activation induces
autophagy in thymocytes through ROS-regulated AMPK and Atg4C
pathways. J Leukoc Biol. 92:421–431. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Sukumaran P, Sun Y, Vyas M and Singh BB:
TRPC1-mediated Ca2+ entry is essential for the
regulation of hypoxia and nutrient depletion-dependent autophagy.
Cell Death Dis. 6:e16742015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Oh HG, Chun YS, Park CS, Kim TW, Park MK
and Chung S: Regulation of basal autophagy by transient receptor
potential melastatin 7 (TRPM7) channel. Biochem Biophys Res Commun.
463:7–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Almasi S, Kennedy BE, El-Aghil M, Sterea
AM, Gujar S, Partida-Sánchez S and El Hiani Y: TRPM2
channel-mediated regulation of autophagy maintains mitochondrial
function and promotes gastric cancer cell survival via the
JNK-signaling pathway. J Biol Chem. 293:3637–3650. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Hosokawa N, Hara T, Kaizuka T, Kishi C,
Takamura A, Miura Y, Iemura S, Natsume T, Takehana K, Yamada N, et
al: Nutrient- dependent mTORC1 association with the
ULK1-Atg13-FIP200 complex required for autophagy. Mol Biol Cell.
20:1981–1991. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Behrends C, Sowa ME, Gygi SP and Harper
JW: Network organization of the human autophagy system. Nature.
466:68–76. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shaw RJ, Bardeesy N, Manning BD, Lopez L,
Kosmatka M, DePinho RA and Cantley LC: The LKB1 tumor suppressor
negatively regulates mTOR signaling. Cancer cell. 6:91–99. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Bort A, Sánchez BG, Spínola E,
Mateos-Gómez PA, Rodriguez- Henche N and Diaz-Laviada I: The red
pepper's spicy ingredient capsaicin activates AMPK in HepG2 cells
through CaMKKβ. PLoS One. 14:e02114202019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Yoshida T, Inoue R, Morii T, Takahashi N,
Yamamoto S, Hara Y, Tominaga M, Shimizu S, Sato Y and Mori Y:
Nitric oxide activates TRP channels by cysteine S-nitrosylation.
Nat Chem Biol. 2:596–607. 2006. View Article : Google Scholar : PubMed/NCBI
|
